Are Zyns Bad for You? It Depends on What They Replace

Are Zyns Bad for You? It Depends on What They Replace

Key Takeaways

• In January 2025 the FDA authorized 20 Zyn products after finding far fewer harmful constituents than in cigarettes and most smokeless tobacco.
• On June 30, 2026 the FDA let Zyn claim a lower risk of several diseases, but only when used instead of cigarettes.
• Nicotine is addictive and raises heart rate and blood pressure, so "less harmful than smoking" does not mean harmless.
• For anyone who does not use nicotine now, the FDA's advice is simple: do not start.

Are Zyns bad for you? Compared with cigarettes, Zyn is far less harmful: the FDA found substantially lower levels of harmful constituents and, in June 2026, authorized Zyn to carry a lower-risk claim versus smoking. Compared with using no nicotine at all, Zyn is not harmless. Nicotine is addictive, raises heart rate and blood pressure, and the pouches irritate gum tissue at the placement site. The honest answer depends on what you were using before, or whether you were using anything at all.

Source: FDA releases, PubMed, and CDC data cited per row.

The reason this table matters: most pages answering "are Zyns bad for you" give a single verdict. A single verdict is misleading. A pack-a-day smoker switching to Zyn and a 16-year-old trying one for the first time are not in the same risk category, and the FDA treats them differently.

Are Zyns Safer Than Cigarettes?

Yes, by the FDA's own review, though the agency is clear that no tobacco product is safe.

On January 16, 2025, the FDA authorized 20 Zyn products (10 flavors, each in 3 mg and 6 mg) for U.S. sale after finding they contained substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products. The agency also found that the products pose a lower risk of cancer and other serious conditions than those combustible and smokeless alternatives.

Then, on June 30, 2026, the FDA went further. It issued modified-risk tobacco product (MRTP) orders for the same 20 products, allowing Zyn to carry this specific claim: "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis."

Three limits worth knowing:

• The claim compares Zyn to cigarettes only, not to dip, snus, vaping, or abstinence.
• The MRTP orders expire in five years, and Swedish Match USA must run postmarket surveillance. The FDA has also said it can withdraw Zyn's marketing orders if youth initiation rises notably.
• "Authorized" is not "approved." In the FDA's own words, authorization does not mean these products are safe, nor that they are "FDA approved."

For the cancer evidence specifically, see Does Zyn Cause Cancer?.

What Does Nicotine Do to Your Body?

Nicotine is the reason tobacco products are addictive, per the FDA. The agency draws a line, though: the toxic mix of chemicals in tobacco smoke, not nicotine itself, causes most of the serious diseases linked to smoking.

That does not make nicotine inert. A 2016 review by Benowitz and Burbank in Trends in Cardiovascular Medicine (PubMed) concluded that nicotine exerts pharmacologic effects that could contribute to acute cardiovascular events. The review noted that the cardiovascular risks of nicotine without combustion products are low compared to cigarette smoking but "still of concern in people with cardiovascular disease." That review looked at e-cigarettes and nicotine medications, not pouches, and pouch-specific long-term heart data are still thin.

For deeper coverage of each angle:

• Is Nicotine Bad for You? covers the full toxicology picture.
• Does Nicotine Raise Blood Pressure? walks through the acute and chronic data.
• Does Nicotine Cause Anxiety? looks at the mental health side.

What Do Pouches Do to Your Mouth?

Irritation at the spot where the pouch sits is the most consistent finding in the limited data available.

A 2024 systematic review in BMC Oral Health (Rungraungrayabkul et al.) found only three studies with a total of 190 participants, all rated high risk of bias. Oral mucosal changes at the placement site were common, ranging from slight wrinkling to various white lesions. Severity appeared to track with the number of pouches used per day and the duration of use. Dry mouth, soreness, and gingival blisters were also reported.

Separately, a 2024 analysis by the German Federal Institute for Risk Assessment (Mallock et al., Tobacco Control) tested 44 nicotine pouches from 20 manufacturers and detected tobacco-specific nitrosamines (TSNAs) in 26 of them, with a maximum of 13 ng NNN per pouch. The study was a market sample, not Zyn-specific, and the brands were not named in the abstract. The authors noted that while pouches may represent a reduced-risk option for smokers, the presence of TSNAs remains a concern.

For a full system-by-system breakdown, see Side Effects of Zyn Pouches.

Is Zyn Bad for Teenagers?

The FDA is unambiguous: nicotine exposure during adolescence can disrupt normal brain development (FDA nicotine page). Federal law, updated in December 2019 under Tobacco 21, sets the minimum sale age for all nicotine products at 21.

Current use among minors is low in percentage terms but large in absolute numbers. The 2024 National Youth Tobacco Survey found that 1.8% of U.S. middle and high school students (about 480,000) reported current nicotine pouch use. Among those pouch users, 68.7% used Zyn.

The risk to younger children is different but acute. A 2025 study in Pediatrics (Olivas et al.) analyzed 134,663 nicotine ingestions among children under 6 from 2010 to 2023. The rate of nicotine pouch ingestions rose 763.1% between 2020 and 2023. Pouches were more likely to cause a serious medical outcome (OR 1.53) or hospital admission (OR 2.03) than other nicotine forms combined. Store cans well out of reach.

Do Zyns Help People Quit Smoking?

The trial evidence is thin. A Cochrane review published in October 2025 identified just four randomized controlled trials with a combined 284 participants, all of whom smoked. The evidence on whether oral nicotine pouches help people quit was rated very uncertain. One small trial suggested lower quit rates compared with e-cigarettes (RR 0.25, 95% CI 0.03 to 2.02), but the confidence interval was wide and included no difference at all. Limited, short-term data did not identify serious health harms from pouch use during the trials.

None of this is enough to recommend pouches as a quitting tool. If you want to stop using nicotine, talk to a clinician about proven options. The quitline is 1-800-QUIT-NOW.

What We Still Do Not Know

Long-term cohort data on nicotine pouch users do not exist yet, so no one can say what decades of daily use will do. The FDA's decisions could not rest on that kind of follow-up. Its MRTP orders expire in five years and require postmarket surveillance, so the agency will have more data before any renewal.

Who Should Not Use Nicotine Pouches

• Anyone who does not already use nicotine. The FDA says those who do not use tobacco should not start.
• Anyone under 21. Federal law (Tobacco 21) prohibits sale of nicotine products to those under 21.
• Pregnant people. Nicotine exposure during pregnancy carries known risks. Talk to your OB.
• People with heart disease or high blood pressure. Nicotine raises heart rate and blood pressure acutely. Discuss any nicotine product with your cardiologist.
• Households with small children or pets. Pouch ingestions in children under 6 are rising fast. Keep cans sealed and stored out of reach.

If you want to quit nicotine, call 1-800-QUIT-NOW or visit smokefree.gov. Nicotine pouches will show up on cotinine tests; for more on that, see Cotinine Test and Nicotine Pouches.

Related from Roon

• Side Effects of Zyn Pouches
• What Does Zyn Do?

Frequently Asked Questions

Is one Zyn a day bad for you?

No study has isolated the risk of a single daily pouch. Even one Zyn delivers nicotine (3 or 6 mg per pouch in the FDA-authorized range), which is addictive and raises heart rate and blood pressure acutely. Fewer pouches may mean less gum irritation, since mouth changes in the 2024 review tracked with pouches per day, but there is no published "safe number." The FDA's position is that no tobacco product is safe.

Is Zyn worse than vaping?

No long-term head-to-head comparison exists. The 2025 Cochrane review found one small trial comparing oral nicotine pouches to e-cigarettes for quitting, but the evidence was too uncertain to draw conclusions. Both deliver nicotine without combustion; neither has multi-decade safety data.

Does Zyn cause cancer?

The FDA found that Zyn exposes users to substantially lower levels of harmful constituents than cigarettes and most smokeless tobacco. The June 2026 modified-risk claim includes lower risk of mouth cancer and lung cancer versus cigarettes. Long-term, pouch-specific cancer data are not yet available. See the full breakdown at Does Zyn Cause Cancer?.

Will Zyn show up on a nicotine test?

Yes. Zyn contains nicotine, which your body metabolizes into cotinine. Standard drug screenings that test for tobacco use look for cotinine, and a nicotine pouch can produce a positive result. For more detail, see Cotinine Test and Nicotine Pouches.

Is Zyn FDA approved?

Zyn is FDA authorized, not approved. The FDA issued marketing granted orders for 20 Zyn products in January 2025 and modified-risk orders in June 2026. The agency itself notes that authorization "does not mean these tobacco products are safe, nor are they 'FDA approved.'"

Ready to Quit the Nicotine, Not the Pouch?

If the habit is what you value, the nicotine is not the only way to keep it. Roon is a zero-nicotine, zero-sugar Cool Mint pouch built around caffeine instead of nicotine. Each one pairs 80 mg caffeine with 60 mg L-theanine, 25 mg methylliberine (Dynamine), and 5 mg theacrine (TeaCrine), and people tend to feel it for 6 to 8 hours, with no jitters and no crash.

That duration comes from the methylliberine: in a randomized, double-blind, crossover PK study (n=12), co-administration of methylliberine with caffeine extended caffeine's half-life from 7.2 to 15 hours and cut oral clearance from 41.9 to 17.1 L/hr, with no increase in peak concentration (study). That trial used 100 mg methylliberine plus 150 mg caffeine, roughly 4x the methylliberine and 1.9x the caffeine in a Roon pouch, so the direction of the effect applies, not the exact magnitudes. A 15-hour half-life is a clearance number, not a claim of 15 hours of alertness. Give yourself at least 8 hours between your last pouch and sleep, and stop at four pouches a day.

Roon costs from $9.16 per tin on a 12-tin subscription, with 15 pouches in each tin. It will not treat nicotine withdrawal, and the safety box above still applies if you are quitting. But if you are ready to quit nicotine pouches without losing the ritual that works for you, try Roon.

Sources

• FDA: Authorizes Marketing of 20 ZYN Nicotine Pouch Products (Jan 16, 2025)
• FDA: Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Modified Risk Claim (Jun 30, 2026)
• FDA: Nicotine Is Why Tobacco Products Are Addictive
• FDA: Tobacco 21
• CDC MMWR: E-Cigarette and Nicotine Pouch Use, NYTS 2024
• Benowitz and Burbank, 2016. Cardiovascular toxicity of nicotine. Trends in Cardiovascular Medicine
• Rungraungrayabkul et al., 2024. Nicotine pouches and oral health: a systematic review. BMC Oral Health
• Mallock et al., 2024. Nicotine and TSNAs in oral nicotine pouches. Tobacco Control
• Olivas et al., 2025. Pediatric nicotine ingestions. Pediatrics
• Hartmann-Boyce et al., 2025. Oral nicotine pouches for cessation. Cochrane Database of Systematic Reviews
• Methylliberine-caffeine PK study. Journal of Exercise and Nutrition

Written by Roon Team